Toni K. Choueiri
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute presents Savolitinib (volitinib, AZD6094, HMPL-504): Future Directions at the 2016 annual International Kidney Cancer Symposium.
Savolitinib (volitinib, AZD6094, HMPL-504): Future Directions
